Literature DB >> 6455443

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

T L Gavan, R N Jones, A L Barry, P C Fuchs, E H Gerlach, J M Matsen, L B Reller, C Thornsberry, L D Thrupp.   

Abstract

A multilaboratory in vitro study was carried out to determine disk diffusion susceptibility testing quality control limits for two new semisynthetic penicillins, mezlocillin and piperacillin. Existing limits for carbenicillin and ampicillin were reevaluated. Multiple tests (which followed standards set by the National Committee for Clinical Laboratory Standards ASM-2 revised) were performed in nine laboratories by different technologists using disks and Mueller-Hinton agar from different manufacturers. Clinically significant differences between disks produced by different manufacturers were not noted. Inhibitory zone diameter measurements from all laboratories were analyzed, and upper and lower control limits were established by using the overall median +/-0.5 the median range of the individual laboratory measurements as determining parameters. Close agreement of the data in this study with the results of national proficiency testing and quality control programs for ampicillin and carbenicillin supports the validity of our approach to making initial recommendations for quality control guidelines for new antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6455443      PMCID: PMC271903          DOI: 10.1128/jcm.14.1.67-72.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  1 in total

1.  Quality control of agar diffusion susceptibility tests.

Authors:  R C Knowles; T D Moore
Journal:  Am J Clin Pathol       Date:  1979-08       Impact factor: 2.493

  1 in total
  60 in total

1.  Antimicrobial susceptibility testing of aquatic bacteria: quality control disk diffusion ranges for Escherichia coli ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658 at 22 and 28 degrees C.

Authors:  R A Miller; R D Walker; A Baya; K Clemens; M Coles; J P Hawke; B E Henricson; H M Hsu; J J Mathers; J L Oaks; M Papapetropoulou; R Reimschuessel
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.

Authors:  A L Barry; J H Jorgensen; D J Hardy; S D Allen; C N Baker; P C Fuchs; J C McLaughlin
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

3.  Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.

Authors:  M J Bale; R N Jones; M E Erwin; F P Koontz; E H Gerlach; P R Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

4.  Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used.

Authors:  T R Anderegg; R N Jones; H S Sader
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing.

Authors:  John Turnidge; Gerry Bordash
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

6.  In vitro antimicrobial activity of a new cephalosporin, ceftaroline, and determination of quality control ranges for MIC testing.

Authors:  Steven D Brown; Maria M Traczewski
Journal:  Antimicrob Agents Chemother       Date:  2008-12-29       Impact factor: 5.191

7.  Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae.

Authors:  P C Fuchs; A L Barry; C Baker; P R Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

8.  Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.

Authors:  A Barry; J Bille; S Brown; D Ellis; J Meis; M Pfaller; R Rennie; M Rinaldi; T Rogers; M Traczewski
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters.

Authors:  A L Barry; P C Fuchs; S D Allen; J H Jorgensen; F C Tenover; P R Murray; D J Hardy; C N Baker
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.

Authors:  M J Bale; R N Jones
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.